Live Breaking News & Updates on Medical science mumbai

Stay informed with the latest breaking news from Medical science mumbai on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Medical science mumbai and stay connected to the pulse of your community

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 16.9% in April

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 2,070,000 shares, a drop of 16.9% from the March 31st total of 2,490,000 shares. Based on an average daily trading volume, of 2,290,000 shares, the days-to-cover […]

Los-angeles , California , United-states , Vanda-pharmaceuticals-inc , Jacobs-levy-equity-management-inc , Nasdaq , Stonepine-capital-management , Capital-partners , Acadian-asset-management , Vanda-pharmaceuticals-company-profile , News-ratings-for-vanda-pharmaceuticals-daily

First Fiduciary Investment Counsel Inc. Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)

First Fiduciary Investment Counsel Inc. lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,314 shares of the company’s stock after purchasing an additional 131 shares during the […]

Venclexta-venclyxto , William-blair , Richarda-gonzalez , Raymond-james , Azita-saleki-gerhardt , England-inc , Torray-investment-partners , First-fiduciary-investment-counsel-inc , Altfest-lj-co , Exchange-commission , Barclays , Synovus-financial-corp

Merck & Co., Inc. (NYSE:MRK) Releases FY 2024 Earnings Guidance

Merck & Co., Inc. (NYSE:MRK – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 8.530-8.650 for the period, compared to the consensus estimate of 8.560. The company issued revenue guidance of $63.1 billion-$64.3 billion, compared to the consensus revenue estimate of $63.8 billion. […]

Steven-mizell , Joseph-romanelli , Societe-generale , Gardasil , Company-profile , Merck-co , Animal-health , News-ratings-for-merck-co , Berenberg-bank , Merck-co-inc , Securities-exchange-commission , Insider-transactions-at-merck-co-inc

Ginkgo Bioworks (NYSE:DNA) Trading 7.9% Higher

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Get Free Report) shares shot up 7.9% on Friday . The stock traded as high as $0.87 and last traded at $0.84. 37,859,880 shares changed hands during mid-day trading, an increase of 50% from the average session volume of 25,304,947 shares. The stock had previously closed at $0.78. Wall […]

Texas , United-states , Marke-dmytruk , Cerity-partners , Securities-exchange-commission , Goldman-sachs-group , Principal-financial-group-inc , Meridian-wealth-management , Raymond-james-associates , Ginkgo-bioworks-holdings-inc , Ginkgo-bioworks-holdings

ImmunityBio (NASDAQ:IBRX) Sees Strong Trading Volume

ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report) shares saw strong trading volume on Friday . 11,462,745 shares were traded during mid-day trading, an increase of 153% from the previous session’s volume of 4,531,350 shares.The stock last traded at $6.33 and had previously closed at $5.11. Wall Street Analysts Forecast Growth Separately, Piper Sandler raised their […]

United-states , Piper-sandler , Simplicity-wealth , Wealth-effects , Virtu-financial , Courier-capital , Immunitybio-inc , Nasdaq , Get-free-report , Capital-management , Immunitybio-daily , Immunitybio

Laboratory Co. of America (NYSE:LH) Releases FY24 Earnings Guidance

Laboratory Co. of America (NYSE:LH – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $14.45-15.35 for the period, compared to the consensus estimate of $14.84. Laboratory Co. of America also updated its FY 2024 guidance to 14.450-15.350 EPS. Analysts Set New Price Targets Several […]

United-states , America , Robertw-baird , Vaart-sandrad-van , Leerink-partnrs , Laboratory-corporation-of-america-holdings , Biopharma-laboratory-services , America-company-profile , News-ratings-for-laboratory-co , Laboratory-co , Securities-exchange-commission , Get-free-report

Cross Staff Investments Inc Increases Stock Holdings in Merck & Co., Inc. (NYSE:MRK)

Cross Staff Investments Inc lifted its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 3.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,710 shares of the company’s stock after buying an additional 225 shares during the quarter. […]

Societe-generale , Steven-mizell , Joseph-romanelli , Gardasil , Securities-exchange-commission , Advisory-group , Wealth-advisors , Animal-health , Cantor-fitzgerald , Berenberg-bank , Rakuten-securities-inc , Insider-activity-at-merck-co-inc

TAP Consulting LLC Takes $225,000 Position in Merck & Co., Inc. (NYSE:MRK)

TAP Consulting LLC purchased a new stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 2,067 shares of the company’s stock, valued at approximately $225,000. Several other hedge funds and other institutional […]

Wellington , New-zealand-general- , New-zealand , United-kingdom , Joseph-romanelli , Gardasil , Societe-generale , Steven-mizell , Insider-activity-at-merck-co-inc , Merck-co-inc , Animal-health , News-ratings-for-merck-co

Bristol-Myers Squibb (NYSE:BMY) Updates FY24 Earnings Guidance

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $0.40-0.70 for the period, compared to the consensus estimate of $0.65. Bristol-Myers Squibb also updated its FY 2024 guidance to 0.400-0.700 EPS. Analyst Upgrades and Downgrades A number of research firms recently […]

United-states , Philadelphia , Pennsylvania , America , Redburn-atlantic , Societe-generale , Pomalyst-imnovid , Bristol-myers-squibb , Bristol-myers-squibb-company , Bristol-myers-squibb-company-profile , Wells-fargo-company , Get-free-report

ResMed Inc. (NYSE:RMD) Shares Acquired by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC boosted its holdings in ResMed Inc. (NYSE:RMD – Free Report) by 4.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 4,397 shares of the medical equipment provider’s stock after buying an additional 198 shares during the period. Motley Fool Asset Management LLC’s holdings in ResMed were worth […]

Peterc-farrell , Mv-capital-management-inc , Motley-fool-asset-management , Jpmorgan-chase-co , Turtle-creek-wealth-advisors , Securities-exchange-commission , Eversource-wealth-advisors , Resmed-inc , Solutions-inc , Operose-advisors , Needham-company